SG11201401362TA - Glucagon binding nucleic acids - Google Patents

Glucagon binding nucleic acids

Info

Publication number
SG11201401362TA
SG11201401362TA SG11201401362TA SG11201401362TA SG11201401362TA SG 11201401362T A SG11201401362T A SG 11201401362TA SG 11201401362T A SG11201401362T A SG 11201401362TA SG 11201401362T A SG11201401362T A SG 11201401362TA SG 11201401362T A SG11201401362T A SG 11201401362TA
Authority
SG
Singapore
Prior art keywords
nucleic acids
binding nucleic
glucagon binding
glucagon
acids
Prior art date
Application number
SG11201401362TA
Other languages
English (en)
Inventor
Werner Purschke
Simone Sell
Axel Vater
Klaus Buchner
Christian Maasch
Sven Klussmann
Original Assignee
Noxxon Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/000089 external-priority patent/WO2012095303A1/en
Application filed by Noxxon Pharma Ag filed Critical Noxxon Pharma Ag
Publication of SG11201401362TA publication Critical patent/SG11201401362TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/30Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG11201401362TA 2011-10-21 2012-10-22 Glucagon binding nucleic acids SG11201401362TA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11008473 2011-10-21
EP11008467 2011-10-21
PCT/EP2012/000089 WO2012095303A1 (en) 2011-01-10 2012-01-10 Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
EP12000107 2012-01-10
PCT/EP2012/004421 WO2013056852A1 (en) 2011-10-21 2012-10-22 Glucagon binding nucleic acids

Publications (1)

Publication Number Publication Date
SG11201401362TA true SG11201401362TA (en) 2014-05-29

Family

ID=48140366

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401362TA SG11201401362TA (en) 2011-10-21 2012-10-22 Glucagon binding nucleic acids

Country Status (12)

Country Link
US (1) US20150232852A1 (enrdf_load_stackoverflow)
EP (1) EP2768960A1 (enrdf_load_stackoverflow)
JP (1) JP2014533098A (enrdf_load_stackoverflow)
KR (1) KR20140083039A (enrdf_load_stackoverflow)
CN (1) CN103958682A (enrdf_load_stackoverflow)
AU (1) AU2012325233A1 (enrdf_load_stackoverflow)
BR (1) BR112014009104A2 (enrdf_load_stackoverflow)
CA (1) CA2852802A1 (enrdf_load_stackoverflow)
IL (1) IL231980A0 (enrdf_load_stackoverflow)
MX (1) MX2014004658A (enrdf_load_stackoverflow)
SG (1) SG11201401362TA (enrdf_load_stackoverflow)
WO (1) WO2013056852A1 (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2802660T (pt) 2012-01-10 2020-04-21 Aptarion Biotech Ag Novos ácidos nucleicos que se ligam a c5a
CN103343126B (zh) * 2013-07-19 2015-12-02 暨南大学 莱克多巴胺适配体与检测莱克多巴胺的适配体电化学生物传感器
US10513536B2 (en) 2014-02-03 2019-12-24 Noxxon Pharma Ag Methods for the preparation of a polyalkoxylated nucleic acid molecule
ES2607639B1 (es) * 2015-09-30 2018-02-28 Urquima, S.A Sal de ácido maleico de un intermedio de silodosina
WO2017062693A1 (en) * 2015-10-07 2017-04-13 Remd Biotherapeutics, Inc. Methods for treating rare genetic disorders using glucagon receptor antagonistic antibodies
DE17829597T1 (de) 2016-11-30 2019-12-05 Noxxon Pharma Ag Verfahren zur polyalkoxylierung von nukleinsäuren zur rückgewinnung und wiederverwendung einer überschüssigen polyalkoxylierungsreagenz
JP7418788B2 (ja) * 2019-10-16 2024-01-22 国立研究開発法人産業技術総合研究所 グルカゴン認識ペプチド並びにグルカゴン検出法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011020A (en) 1990-06-11 2000-01-04 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand complexes
US6395029B1 (en) 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
US6677136B2 (en) * 2000-05-03 2004-01-13 Amgen Inc. Glucagon antagonists
US6652886B2 (en) 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
US7629456B2 (en) 2001-10-26 2009-12-08 Noxxon Pharma Ag Modified L-nucleic acid
EP1306382A1 (de) 2001-10-26 2003-05-02 Noxxon Pharma AG Modifizierte L-Nukleinsäure
WO2003070823A2 (en) 2002-02-20 2003-08-28 The General Hospital Corporation Conjugates comprising a biodegradable polymer and uses therefor
AU2004230927B9 (en) 2003-04-13 2011-12-01 Enzon Pharmaceuticals, Inc. Polymeric oligonucleotide prodrugs
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
CN1917905B (zh) 2004-02-09 2012-01-04 诺松制药股份公司 从多糖和多核苷酸生产缀合物的方法
DK1732607T3 (da) 2004-03-23 2019-07-22 Ascendis Pharma Gmbh Polymer-prodrug med en selvofrende linker
EP1807092B1 (en) 2004-11-05 2016-09-07 The Children's Hospital of Philadelphia Biodegradable linkers for molecular therapies
US8497250B2 (en) * 2005-05-04 2013-07-30 Noxxon Pharma Ag Use of spiegelmers to inhibit an intracellular target molecule
JP4706019B2 (ja) * 2005-07-08 2011-06-22 国立大学法人東京農工大学 アプタマーの同定方法
MX2009002859A (es) 2006-09-15 2009-03-30 Enzon Pharmaceuticals Inc Enlazadores biodegradables a base de ester impedido para suministro de oligonucleotidos.
US20100062436A1 (en) 2006-10-31 2010-03-11 Noxxon Pharma Ag Methods for Detection of a Single- or Double-Stranded Nucleic Acid Molecule
JP2014504865A (ja) * 2011-01-10 2014-02-27 ノクソン ファーマ エージー 標的分子との結合親和性を有する核酸分子およびその生成方法

Also Published As

Publication number Publication date
AU2012325233A1 (en) 2014-04-24
EP2768960A1 (en) 2014-08-27
JP2014533098A (ja) 2014-12-11
US20150232852A1 (en) 2015-08-20
CA2852802A1 (en) 2013-04-25
MX2014004658A (es) 2015-08-13
CN103958682A (zh) 2014-07-30
KR20140083039A (ko) 2014-07-03
IL231980A0 (en) 2014-05-28
BR112014009104A2 (pt) 2017-04-18
WO2013056852A1 (en) 2013-04-25
AU2012325233A2 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
IL270223B (en) Molecules that specifically bind tdp–43
IL231983A0 (en) Dna containing tricyclo-phosphorothioate
DK2922554T3 (en) Terminalt modificeret rna
ZA201205891B (en) Dna polymerases
SI3018211T1 (sl) Protismiselne nukleinske kisline
EP2797585A4 (en) STABILIZED GLUCAGONNANOULULSIONS
ZA201404481B (en) Il-1 binding proteins
IL235325A0 (en) Nucleic acid extraction
GB201118636D0 (en) Nucleotide sequence
IL233516A0 (en) C5a binding amino acids
EP2807588A4 (en) SEQUENCING ELECTRONIC FILES
IL231980A0 (en) Glucagon binding nucleic acids
IL233515A0 (en) Amino acids that specifically bind cgrp
EP2709853A4 (en) BINDER
EP2844775A4 (en) DNA SEQUENCING
GB201208942D0 (en) Extraction control for RNA
GB201200563D0 (en) Binding molecule
GB201107286D0 (en) Nucleic acid preparation
HK1195923A (en) Glucagon binding nucleic acids
GB201113890D0 (en) Binding surfaces
GB201108573D0 (en) Binder
GB201108575D0 (en) Binder
GB201214293D0 (en) Binding surfaces
GB201103961D0 (en) Binding polypeptides
GB201110613D0 (en) Comb binding